阿司匹林抗癌作用终于出指南了

2016-11-02 叶子 解螺旋

作为医药史上三大经典药物之一阿司匹林(另两个是青霉素、安定),在其穿越了百年的风雨沉浮之后,焕发出了新的光彩。美国预防服务工作组发表的新指南中,阿司匹林作为心血管疾病和结直肠癌的一级预防药物。关于阿司匹林与癌症的关系,众说纷纭,现在这个问题终于有定论了。美国预防服务工作组的指南,正式将阿司匹林作为了结直肠癌的一级预防药物。 早在2012年《Lancet》3月刊刊登了牛津大学的研究证实


作为医药史上三大经典药物之一阿司匹林(另两个是青霉素、安定),在其穿越了百年的风雨沉浮之后,焕发出了新的光彩。美国预防服务工作组发表的新指南中,阿司匹林作为心血管疾病和结直肠癌的一级预防药物。

关于阿司匹林与癌症的关系,众说纷纭,现在这个问题终于有定论了。美国预防服务工作组的指南,正式将阿司匹林作为了结直肠癌的一级预防药物。 

早在2012年《Lancet》3月刊刊登了牛津大学的研究证实了阿司匹林有抗胰腺癌的作用。该研究针对英国本土的心血管患者,试验组每天服用阿司匹林(≥75mg),记录所有患者癌症发生率。结果发现,日常服用阿司匹林可减低胰腺癌发病率,同时,几年后其降低死亡率的作用也显现出来,表明阿司匹林能抑制肿瘤生长和转移。随着研究的深入,科学家还从生化途径角度解释了阿司匹林的防癌机制,认为与其可大幅减少血液及两个结直肠癌细胞系中2-羟戊二酸(癌症的驱动因子)的含量有关。


2016年4月11日的《Ann Intern Med》上发表了阿司匹林作为心血管疾病和结直肠癌一级预防用药的指南(http://annals.org/aim/article/2513179/aspirin-use-primary-prevention-cardiovascular-disease-colorectal-cancer-u-s),最终推荐认为:10年心血管风险≥10%且无出血风险增加的50~69岁人群,应考虑服用低剂量阿司匹林来预防心血管病和结直肠癌。指南的推荐是对2009年USPSTF阿司匹林预防心血管病推荐及2007年阿司匹林预防结直肠癌推荐的更新。 

两个神药的结构都很简单


和之前我们也介绍过的另一个跨界神药——二甲双胍的抗癌作用(实力跨界新选手,教你如何厮杀癌症领域)一样,阿司匹林在其穿越了百年的风雨沉浮之后,依然魅力不减历久弥新,所谓经典,名不虚传。

抗癌之外的阿司匹林功效

热镇痛作用

迄今为止尽管人们已经掌握了大量与疼痛有关的知识,但疼痛的机理仍没有彻底阐明。按照现阶段人类对疼痛的理解,当疼痛发生时,局部将产生并释放某些致痛的化学因子如缓激肽等,同时产生和释放的还有前列腺素。缓激肽作用于痛觉感受器即可引起疼痛,前列腺素则可使痛觉感受器对缓激肽等致痛因子的敏感性提高,也即前列腺素对缓激肽等导致的疼痛起到了放大作用。

阿司匹林镇痛就是因为它能抑制体内前列腺素的生物合成,从而减弱通过神经传递到大脑中的信号。退热也是一样,实验证明,全身组织产生的多种前列腺素都有致热作用,微量的前列腺素注入动物脑室内即可引起发热。阿司匹林可以通过抑制体温调节中枢内前列腺素的合成而发挥解热作用,但对体温正常者却无降温作用。 

目前就解热镇痛药来说,扑热息痛(对乙酰氨基酚)、芬必得(布洛芬)等新一代产品不但治疗效果更胜一筹,副作用也有所减低,更容易被机体耐受。因此,如果仅用于解热镇痛,阿司匹林似乎是要被淘汰了。但为何现在全世界每年消耗阿司匹林超过1000亿片呢?
用于心血管疾病

现在的阿司匹林更多的用于心血管疾病的预防,能预防血小板的凝结,可以减轻血栓带来的危险。2009年5月美国预防署特别工作组(USPSTF)发布《阿司匹林用于预防心血管病:USPSTF推荐指南》,修订了阿司匹林用于心血管病一级预防的推荐内容: 

①45~79岁的男性,在降低心肌梗死的益处超过增加胃肠道出血的风险时,推荐使用阿司匹林; 

②55~79岁的妇女,在降低缺血性脑卒中的益处超过增加胃肠道出血的风险时,推荐使用阿司匹林; 

③在80岁以上老年人群中,现有资料不足以评价阿司匹林用于一级预防的效益与风险; 

④不推荐55岁以下妇女用阿司匹林预防脑卒中或45岁以下男性用阿司匹林预防心肌梗死 

除了以上这些,阿司匹林还有什么作用呢? 

用于多种神经性疾病 

阿司匹林的一种组分可以同名为GAPDH的酶类相结合,GAPDH被认为在神经变性疾病中扮演重要角色,比如阿尔兹海默氏症、帕金森疾病和亨廷顿氏症等。经常服用阿斯匹林的老年人患老年痴呆和认知障碍的危险性明显降低。小剂量阿司匹林可以减少老年痴呆症恶化。这是因为阿司匹林具有增强脑血流量,防止血液凝固的作用。 

帮助免疫治疗 

《Cell》上的一项研究表示,在进行肿瘤免疫治疗的同时服用阿司匹林可以大大提高治疗效果。研究人员们通过研究证明皮肤癌,乳腺癌和大肠癌细胞经常会产生大量前列腺素E2(PGE2),这种分子能够减弱免疫系统对病变细胞的正常应答,帮助癌细胞进行隐藏,这一过程使得肿瘤能够快速生长,也部分解释了为什么一些免疫治疗方法不能达到预期效果。 

阿司匹林是COX抑制剂的一种,这种药物能够抑制PGE2的合成达到重新唤醒免疫系统的效果。因此与单独使用免疫疗法相比,将免疫治疗方法与阿司匹林或其他COX抑制剂联合使用能够大大减缓小鼠体内大肠癌或黑色素瘤的生长。
老年性白内障 

阿司匹林对老年性白内障的病程发展可能有一些延缓的作用。可使本病形成推迟10年,可减少45%或更多的患者免于手术。其确切抑制机制临床应用等问题有待进一步研究。有研究认为白内障患者血浆中色氨酸含量增高致晶体中醛糖还原糖活性增高,而阿司匹林不仅可抑制醛糖还原酶活性,还可降低血浆中色氨酸的含量,故认为阿司匹林至少可减缓白内障的发生。

先兆子痫 

先兆子痫患者胎盘组织和血小板比正常妊娠者全盛显著增多的TXA2,而胎盘,脐带PGI2及尿中排出PGI2代谢物则减少,正常的PGI2/TXA2平衡被破坏。因此用小剂量APC恢复此平衡,可望预防或治疗该病。 

女性不孕和习惯性流产 

阿司匹林可抑制PG合成,可用于治疗由于PG增高所至的习惯性流产和不孕症,因为体内PG增高可促进输卵管蠕动加强,破坏受精卵与子宫内膜的同步作用,增加了子宫收缩力,使卵巢黄体分泌孕酮降低而影响受精卵的着床。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (46)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-15 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-14 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-13 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-12 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-11 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-10 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-09 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-08 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-07 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=162926, encodeId=9ad316292616, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 15 07:18:34 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162633, encodeId=5e8b16263318, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 14 06:54:55 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162353, encodeId=ae77162353e8, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 13 07:24:53 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=162090, encodeId=add5162090cf, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Dec 12 07:19:18 CST 2016, time=2016-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161865, encodeId=427b161865f3, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Dec 11 07:22:49 CST 2016, time=2016-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161576, encodeId=c9de1615e685, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 10 06:27:57 CST 2016, time=2016-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161355, encodeId=75f216135501, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 09 07:25:50 CST 2016, time=2016-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=161088, encodeId=c5fe1610885e, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 08 06:48:59 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160827, encodeId=25b316082e05, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Dec 07 07:25:40 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160572, encodeId=23f31605e2ef, content=学习和应用阿司匹林抗癌指南。, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Dec 06 06:57:11 CST 2016, time=2016-12-06, status=1, ipAttribution=)]
    2016-12-06 jyzxjiangqin

    学习和应用阿司匹林抗癌指南。

    0

相关资讯

Eur J Heart Fail:合用阿司匹林会降低依普利酮有益效应吗?

研究结果表明慢性收缩性心力衰竭和轻度症状的患者使用阿司匹林并不会降低依普利酮的整体有益效应。

阿司匹林的这些不良反应,一定要知道!

阿司匹林是一款有着百年历史的老药,小到解热镇痛,大到预防恶性肿瘤,可谓一款“神药”。在应用这款“神药”时,有以下问题需要注意:不良反应1、胃肠道反应① 临床表现:上腹不适、恶心、呕吐; ② 较大剂量时(抗风湿治疗)引起胃溃疡和无痛性胃出血,原有溃疡者症状加重,其发生机制:a、直接刺激胃粘膜;b、抑制胃壁组织环加氧酶,减少PGE2的生成,胃壁前列腺素对胃粘膜有保护作用;c、血浓度高则刺激延

长期服用阿司匹林,应注意的8大问题

许多中老年人为预防心脑血管病的发生而长期服用阿司匹林(ASA)。但随着低剂量ASA在临床上的广泛应用,其不良反应也很多见,长期服用阿司匹林应引起人们的重视。一、阿司匹林的危害1、对胃肠道粘膜的损害值得关注ASA 对胃肠道粘膜产生损害的机制主要有局部作用和系统作用两方面:① 局部损害。② 系统作用:最容易导致胃的消化性溃疡,发生出血、穿孔;同时低剂量ASA长期应用也可致食管、小肠、结直肠的损伤,

盘点:近期阿司匹林重要研究汇总

阿司匹林(Aspirin)又称之为乙酰水杨酸,是一种历史悠久的解热镇痛药,我们都知道这种药物可以用于治感冒、发热、头痛、牙痛、关节痛、风湿病,还能抑制血小板聚集,用于预防和治疗缺血性心脏病、心肺梗塞、脑血栓形成等疾病。本文中小编盘点了近期阿司匹林的一些重要研究进展。【1】Lancet:TIA或缺血性卒中后预防复发性卒中,越早服用阿司匹林越好临床试验表明阿司匹林可以降低复发性卒中13%的长期风险

含阿司匹林中成药还能吃吗

10月12日,国家食品药品监管总局发布药品安全警示民众:谨慎使用含阿司匹林的中成药,并指出长期服用含阿司匹林的中成药有可能会造成凝血方面的问题。 一石激起千层浪,引起大家热议。民众关心的问题主要集中在三个方面:含阿司匹林中成药受到安全警示,那么其他含阿司匹林的药是否也存在安全隐含?日常服用阿司匹林有哪些不良反应,用药需要注意什么?“三高”患者还能长期服用阿司匹林吗?

Stroke:预防动脉粥样硬化性卒中复发:氯吡格雷联合阿司匹林VS阿司匹林

背景:由大动脉动脉粥样硬化引起的急性缺血性卒中患者中,预防复发性脑缺血的发生,氯吡格雷联合阿司匹林vs阿司匹林单独治疗可能更有效。然而,没有明确的证据。方法:在这项多中心、双盲、安慰剂对照试验中,研究者随机对358例疑似大动脉粥样硬化起源急性缺血性脑卒中患者,在发病48小时内服用氯吡格雷(75 mg/d无负荷剂量)联合阿司匹林(300 mg负荷剂量后100mg/d)或单用阿司匹林(300 mg/d